Innovaccer Added Former Allscripts CEO to Board
The San Francisco health tech firm appointed Paul Black to its board of directors effective October 1.
Updated on Oct. 1, 2026 in Healthcare
Live Poll
Do you support using private health data to power AI-driven infrastructure in the medical field?
San Francisco-based Innovaccer has added Paul Black to its board of directors, looking to lean on his extensive background in health data and systems. Black joins the company as it continues to grow its Healthcare Autonomy Platform.
Why it matters
The move brings significant industry experience to a local firm that unifies clinical and financial data. Black currently advises more than eight other AI-focused companies, marking a continued trend of tech leadership shifting toward automation and integration within healthcare.
During his 13-year tenure at Cerner, Black helped grow annual revenue from $100 million to more than $1.5 billion. He also currently serves as an adviser or board member to more than eight other AI companies.
The players
Innovaccer
A San Francisco-based company that operates a platform unifying clinical, claims, and operational data for health systems.
Paul Black
A veteran health-tech executive who previously led Allscripts and currently advises multiple artificial intelligence firms.
CommonSpirit Health
A major health system headquartered in Chicago that appointed Black to its Board of Stewardship Trustees in 2025.
The details
Innovaccer, which maintains its headquarters in San Francisco, announced the appointment following the release of a company news statement. Black brings extensive experience including a decade as CEO of Allscripts and 16 years on the executive committee of Truman Medical Centers. He was also appointed to the CommonSpirit Health Board of Stewardship Trustees in 2025.
Timeline
2012-2022: Paul Black led Allscripts as CEO.
2025: CommonSpirit Health appointed Paul Black to its board.
October 1, 2026: Innovaccer appointed Paul Black to its board.
Across the Bay
This appointment follows the broader industry move toward data unification established by the ONC's Cures Act Final Rule on health interoperability. Innovaccer is effectively positioning itself to capitalize on the increasing regulatory and clinical demand for seamless system integration.
There is no immediate change for San Francisco residents regarding local healthcare access or service. The change is strictly a shift in the corporate governance of a firm headquartered in the city.
The takeaway
The appointment suggests that Innovaccer is prioritizing the integration of AI into its data platform to remain competitive. Keep an eye on any new product launches or software updates the company releases in the coming year.
Further reading
For more updates on the city's growing medical technology sector, visit San Francisco Healthcare.
Live Poll
Do you support using private health data to power AI-driven infrastructure in the medical field?
